Dr. Camillo Ricordi Named Distinguished Professor of Medicine

Miami, FL (May 25, 2007) — Camillo Ricordi, M.D., scientific director and chief academic officer of the Diabetes Research Institute at the University of Miami Leonard M. Miller School of Medicine, has been appointed a Distinguished Professor of Medicine at the University of Miami. Ricordi is only the seventh faculty member across the entire University to receive this honor, which is the highest distinction a professor can achieve at UM.

“Dr. Ricordi’s extraordinary research in the field of islet cell transplantation as a possible cure for type 1 diabetes has markedly advanced the pace of discovery around the world,” said Donna E. Shalala, president of the University of Miami. “His groundbreaking work has brought distinction to our University and School of Medicine, and it is only fitting that he be recognized for his contributions.”

The University of Miami received an anonymous gift to its Momentum campaign that created the new professorships to honor outstanding faculty scholars. In conjunction with the appointment, Dr. Ricordi will receive a $25,000 annual research fund to be used in support of his scholarly activities.

“At the Miller School of Medicine we are extremely proud of this tremendous recognition of the scientific achievements of Camillo Ricordi,” said Pascal J. Goldschmidt, M.D., senior vice president for medical affairs and dean of the Miller School of Medicine. “He has set the standard for research, always building teams and reaching out collaboratively to other colleagues, so they can all work together in an interdisciplinary approach to solve the mystery and negative health impact of one of our most debilitating diseases.”

Ricordi also serves as chief of the Division of Cellular Transplantation at the Miller School of Medicine, and the Stacy Joy Goodman Professor of Surgery. Renowned as one of the world’s leading scientists in cell transplantation, he is well known for inventing the machine that made it possible to isolate large numbers of insulin-producing islet cells from a donor pancreas. Ricordi performed the first series of clinical islet transplants in patients with diabetes, many of whom were able to come off insulin completely or greatly reduce their need for the medication.

“I am very grateful to the University of Miami for this exceptional honor and recognition,” said Ricordi. “However, the determinants of our success are the exceptional faculty and staff, who are the heart and soul of the Diabetes Research Institute, and our amazing supporters and staff at the Diabetes Research Institute Foundation. Together, these two teams have made our research progress possible, and I accept this great recognition on their behalf and I look forward to the real celebration when we find the cure for diabetes.”

Media Contact:
Jeanne Antol Krull

Keep Up With Our Progress Toward A Cure & More